Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure
复制标题
DOI：
10.3748/wjg.v19.i48.9432
复制
发表时间：
2013-12-28
影响因子：
4.3
通讯作者：
Xin, Shao-Jie
中科院分区：
文献类型：
--
作者：
Wan, Zhi-Hong;Wang, Jian-Jun;Xin, Shao-Jie
目的：探讨血清胱抑素 C 水平作为预测慢加急性肝衰竭 (ACLF) 患者急性肾损伤 (AKI) 的早期生物标志物。 方法：连续 56 名血清肌酐 (Cr) 水平正常的乙型肝炎病毒相关 ACLF 患者（
AIM: To investigate serum cystatin C level as an early biomarker for predicting acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF).METHODS: Fifty-six consecutive patients with hepatitis B virus-related ACLF who had normal serum creatinine (Cr) level (